Industry Briefs: Mar. 19, 2012 - Pharmaceutical Technology

Latest Issue

Latest Issue
PharmTech Europe

Industry Briefs: Mar. 19, 2012
A roundup of additional company and people news from pharmaceutical and biopharmaceutical companies, their suppliers, and contract-service providers.

Company News

Bend Reasearch has launched a biotherapeutics-development initiative. Read More

OctoPlus has formed an agreement with a top-five generic-drugs company for the development of a formulation for an injectable drug. Read More

QRxPharma has signed a license and option agreement with Actavis. Read More

Recipharm has been contracted by ViroPharma to complete a full commercial scale-up manufacture of DuoCort’s Plenadren (hydrocortisone modified-release tablet). Read More

Shire plans to acquire FerroKin BioSciences for an upfront payment of $100 million. Read More

ThromboGenics has formed a commercialization agreement for Ocriplasmin with Alcon. Read More

People News

Stuart E. Needleman has been named president and chief operating officer of Aptuit, effective immediately. Read More

Avanir Pharmaceuticals has appointed Rohan Palekar as chief commercial officer. Read More

Unigene has appointed David Moskowitz as chief financial officer. Read More


blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
| Weekly

FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
View Results
Jim Miller Outsourcing Outlook Jim Miller Health Systems Raise the Bar on Reimbursing New Drugs
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerThe Mainstreaming of Continuous Flow API Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler Industry Seeks Clearer Standards for Track and Trace
Siegfried Schmitt Ask the Expert Siegfried SchmittData Integrity
Sandoz Wins Biosimilar Filing Race
NIH Translational Research Partnership Yields Promising Therapy
Clusters set to benefit from improved funding climate but IP rights are even more critical
Supplier Audit Program Marks Progress
FDA, Drug Companies Struggle with Compassionate Use Requests

Click here